TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Surface Area of Split-thickness Skin Graft Incorporation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: muscle weakness and atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of Bladder Irritation Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Loin Pain Scores From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCINEXA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of GH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Level of RDW
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tolerability (compliance)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Foot health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of digestive and non-digestive bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Reported Outcomes Measurement Information System (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional Assessment of Cancer Therapy-General (FACT-G)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceptions of cure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of maternal medicines in human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of tests performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in diastolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: level of masticatory efficiency in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate ratio of intra-dialytic hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the mandibular length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood Autism Rating Scale, 2nd Edition (CARS-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vineland Scales of Adaptive Behavior, 3rd Edition (Vineland 3)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Internalizing and Externalizing Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in modified Sequential Organ Failure Assessment score (mSOFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Optimism/Positive Future Expectancies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Limit of stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth hormone dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Super-resolution ultrasound image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Central catheter-associated bloodstream infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Ventilator-associated Event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Catheter-associated Urinary Tract Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Peak knee extensor torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tic Frequency With Stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Tic Intensity With Stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the serum concentration-time curve (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal elimination half-life (T^1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transition time to full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in weight before and after feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine albumin-to-creatinine ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Minimal Response (MR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited and unsolicited serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequencies of CD4+ T cells that produce Tat/Rev transcription
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GMT fold-rise for neutralising antibodies against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency and severity of solicited AEs after VLA2001 booster vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Prenatal Attachment Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Stress Scale 10
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Procedure impact
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Opioid Misuse
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive-deterioration-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Assessment of pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Compliance of Dietary Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance of Supplementation Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Macular Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Macular Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Vascular Endothelial Growth Factor (VEGF) level in Anterior Chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of oral mucositis (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported oral mucositis pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Change in Student Prosocial Behavior Scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean Change in Student Optimism Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Change in Teacher Burnout Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients with at least one OM grade >2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Solicited Local Reactions and Systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titers (GMT) for RSV/A, RSV/B, hMPV/A, and hMPV/B-specific Neutralizing Antibodies (NAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With a >=4-fold Increase in Serum anti-RSV/A, RSV/B, hMPV/A, and hMPV/B-specific NAb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: E. coli detection in drinking water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Heavy metals or other contaminants exceeding EPA MCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the proportion of PD1+CD38+ CD8+ and CD4+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the proportion of Ki67+ CD8+ and CD4+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Heart rhythm after DCCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of Dysmenorrheic Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annual bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: clinical changes in arthropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sum of Total Pain Relief (TOTPAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial endotoxin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lipoteichoic acid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Client Service Receipt Inventory - RAre disease (CSRI-Ra)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Posttraumatic Stress Disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attachment styles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Navicular Drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Efavaleukin Alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of the Maximum Observed Serum Concentration (Tmax) of Efavaleukin Alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration Time Curve From Time Zero to Time of Last Quantifiable Concentration (AUClast) of Efavaleukin Alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration Time Curve From Time Zero to Infinity (AUCinf) of Efavaleukin Alfa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to GLI-LEEF
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in urinary androgen metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in urinary oestrogen metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in urinary progesterone metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in urinary aldosterone metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in urinary corticosterone metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in urinary cortisone metabolite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Two-years progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change of Prolonged Grief Disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Post-Traumatic Stress Disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Anticipatory Grief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Device technical success and absence of reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Absence of aortic rupture, lesion-related mortality, disabling stroke, permanent paraplegia, permanent paraparesis, and new onset renal failure requiring permanent dialysis
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of muscle-invasive bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional status using Karnofsky performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of vaginal self-test and urinary self-sampling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hemostatic efficacy in on-demand treatment of acute bleeding episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hemostatic efficacy in perioperative management of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of life by constipation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of symptoms of Long COVID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants clinically recovered
Endpoint domain: Mortality/survival
Primary endpoint: Severity of the Long COVID symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Functional Outcome of Sleep Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Epworth Sleepiness Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Berlin Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in STOP-BANG questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Insomnia questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Restless Legs Syndrome questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total Number of Retrieved Lymph Nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in the Peak-Pruritus Numerical Rating Scale (PP-NRS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of infection with Plasmodium falciparum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: IV catheterization skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: IM injection skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: information levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with non-healing wounds
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with poor scarring requiring additional (unplanned) operation
Endpoint domain: Adverse events/effects
Primary endpoint: Breath hydrogen AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the degree of lumbopelvic instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lumbopelvic range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Compliance rate of the RTE meals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blood Ketones Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline Invasive Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline Post-Puncture Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUCt of Lobeglitazone, Empagliflozin, Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of Lobeglitazone, Empagliflozin, Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oral microbiota profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nitrite/Nitrate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ED symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epidemiology of lupus nephritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quality of life evaluated through Quality of Life - Alzheimer's Disease (QoL-AD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in quality of life evaluated through EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in AUDIT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CIWA-Ar score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PACS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Nodal metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: percentage of HbA1c change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver transplant free survival
Endpoint domain: Mortality/survival
Primary endpoint: liver steatosis index CAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission or mortality related to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Time taken to self-report recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression to severe COVID-19 Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of primary fascial closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Walking Speed without neurostimulation assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paretic Propulsion without neurostimulation assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propulsion Impulse without neurostimulation assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propulsion Symmetry without neurostimulation assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose Time-in-Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of PEDOT:PSS microECoGs
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive Attentional Syndrome Scale (CAS-1)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Metacognitions Questionnaire - 30 (MCQ-30)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitions Concerning Suicide Scale (CCSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of circulating T-follicular helper and T-follicular regulatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of cases of successful extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Organ Function Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory Markers Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Oldenburg Burnout Inventory score (OLBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Percieved Stress Scale score (PSS-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in well-being score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in subjective health score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax Xanthohumol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax Xanthohumol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral bioavailability Xanthohumol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear wave elastography measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Perceived Stress Scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral regulation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Need for airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Parental Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parenting Sense of Competence Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ridge dimension changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of endocrine organs involved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes